NEWS TIPS & FEATURES

mealplanning copy

6 Steps for Simple Meal Planning

Planning ahead will allow you to reap the benefits of healthier and less expensive home-cooked meals. By Heidi Reichenberger McIndoo, MS, RD, LDN If you are scrambling to get dinner on the table every... [...]


Addition of Eloxatin® Following Surgery Delays Cancer Progression in Certain Colorectal Cancers

The addition of the chemotherapy combination consisting of Eloxatin (oxalipatin) plus 5-fluorouracil (5 FU) following surgery reduces the risk of cancer progression among patients with deficient mismatch... [...]


Neratinib Improves Cancer-Free Survival in Early Breast Cancer

The targeted agent neratinib (PB272), which is still in clinical trials, demonstrated an improvement in cancer-free survival when used after Herceptin® (trastuzumab) in early-stage, HER2-positive breast... [...]


Cabozantinib Does Not Demonstrate Improvements in Advanced Prostate Cancer

In a recent study, the targeted agent cabozantinib did not demonstrate an improvement in outcomes compared to prednisone, among men with advanced prostate cancer. These results were recently published... [...]


3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma

Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... [...]


Amy Gibson Creates FIRST Cancer HairCARE Center for CancerConnect.com

Amy Gibson Author | Emmy Nominated Soap Opera Star | Cancer Hair Loss Expert Leading Hair Loss Consultant Amy Gibson breaks new ground again, creating the Cancer HairCARE Center by Amy Gibson premiering... [...]


Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101

Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... [...]


Summer Camp Support Network for Children Affected by a Parent’s Cancer

Camp Kesem at Syracuse University is a free, week-long summer camp for children affected by a parent’s cancer. Over 3 million children live with a parent with cancer, many more have lost a parent to... [...]


FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for Cancer Treatment

The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths. Chimeric... [...]


« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS